Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes

S. Russo, M. Marchi, F. Cogliati, M. T. Bonati, M. Pintaudi, E. Veneselli, V. Saletti, M. Balestrini, B. Ben-Zeev, L. Larizza

Research output: Contribution to journalArticle

Abstract

It has been found that CDKL5 gene mutations are responsible for early-onset epilepsy and drug resistance. We screened a population of 92 patients with classic/atypical Rett syndrome, 17 Angelman/Angelman-like patients and six idiopathic autistic patients for CDKL5 mutations and exon deletions and identified seven novel mutations: six in the Rett subset and one in an Angelman patient. This last, an insertion in exon 11, c.903-904 dupGA, p.Leu302Aspfx49X, is associated with a relatively mild clinical presentation as the patient is the only one capable of sitting and walking alone. Of the six mutations, two are de novo missense changes affecting highly conserved aminoacid residues, c.215 T>C p.Ile72Thr and c.380A>G p.His127Arg (present in a mosaic condition) found in two girls with the most severe clinical presentation, while the remaining are the splicing c.145+2 T>C and c.2376+5G>A, the c.1648C>T p.Arg550X and the MPLA-identified c.162-99del261 mutation. RNA characterisation of four mutations revealed the aberrant transcript of the missense allele (case 2) and not the stop mutation (case 3), but also allowed the splicing mutation (case 1) and the c.-162-99del261 (case 4) to be categorised as truncating. The obtained data reinforce the view that a more severe phenotype is due more to an altered protein than haploinsufficiency. Furthermore, the mutational repertoire of the CDKL5 gene is shown to be expanded by testing patients with phenotypical overlap to Rett syndrome and applying multiplex ligation-dependent probe amplification.

Original languageEnglish
Pages (from-to)241-250
Number of pages10
JournalNeurogenetics
Volume10
Issue number3
DOIs
Publication statusPublished - Jul 2009

Fingerprint

Phenotype
Mutation
Genes
Exons
Rett Syndrome
Haploinsufficiency
Sequence Deletion
Multiplex Polymerase Chain Reaction
Drug Resistance
Walking
Epilepsy
Alleles
RNA
Population
Proteins

Keywords

  • Genotype-phenotype correlation
  • Mutation screening
  • RNA analysis

ASJC Scopus subject areas

  • Genetics(clinical)
  • Cellular and Molecular Neuroscience
  • Genetics

Cite this

Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. / Russo, S.; Marchi, M.; Cogliati, F.; Bonati, M. T.; Pintaudi, M.; Veneselli, E.; Saletti, V.; Balestrini, M.; Ben-Zeev, B.; Larizza, L.

In: Neurogenetics, Vol. 10, No. 3, 07.2009, p. 241-250.

Research output: Contribution to journalArticle

@article{dc60aa49682a4649b7c95deae8c2b014,
title = "Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes",
abstract = "It has been found that CDKL5 gene mutations are responsible for early-onset epilepsy and drug resistance. We screened a population of 92 patients with classic/atypical Rett syndrome, 17 Angelman/Angelman-like patients and six idiopathic autistic patients for CDKL5 mutations and exon deletions and identified seven novel mutations: six in the Rett subset and one in an Angelman patient. This last, an insertion in exon 11, c.903-904 dupGA, p.Leu302Aspfx49X, is associated with a relatively mild clinical presentation as the patient is the only one capable of sitting and walking alone. Of the six mutations, two are de novo missense changes affecting highly conserved aminoacid residues, c.215 T>C p.Ile72Thr and c.380A>G p.His127Arg (present in a mosaic condition) found in two girls with the most severe clinical presentation, while the remaining are the splicing c.145+2 T>C and c.2376+5G>A, the c.1648C>T p.Arg550X and the MPLA-identified c.162-99del261 mutation. RNA characterisation of four mutations revealed the aberrant transcript of the missense allele (case 2) and not the stop mutation (case 3), but also allowed the splicing mutation (case 1) and the c.-162-99del261 (case 4) to be categorised as truncating. The obtained data reinforce the view that a more severe phenotype is due more to an altered protein than haploinsufficiency. Furthermore, the mutational repertoire of the CDKL5 gene is shown to be expanded by testing patients with phenotypical overlap to Rett syndrome and applying multiplex ligation-dependent probe amplification.",
keywords = "Genotype-phenotype correlation, Mutation screening, RNA analysis",
author = "S. Russo and M. Marchi and F. Cogliati and Bonati, {M. T.} and M. Pintaudi and E. Veneselli and V. Saletti and M. Balestrini and B. Ben-Zeev and L. Larizza",
year = "2009",
month = "7",
doi = "10.1007/s10048-009-0177-1",
language = "English",
volume = "10",
pages = "241--250",
journal = "Neurogenetics",
issn = "1364-6745",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes

AU - Russo, S.

AU - Marchi, M.

AU - Cogliati, F.

AU - Bonati, M. T.

AU - Pintaudi, M.

AU - Veneselli, E.

AU - Saletti, V.

AU - Balestrini, M.

AU - Ben-Zeev, B.

AU - Larizza, L.

PY - 2009/7

Y1 - 2009/7

N2 - It has been found that CDKL5 gene mutations are responsible for early-onset epilepsy and drug resistance. We screened a population of 92 patients with classic/atypical Rett syndrome, 17 Angelman/Angelman-like patients and six idiopathic autistic patients for CDKL5 mutations and exon deletions and identified seven novel mutations: six in the Rett subset and one in an Angelman patient. This last, an insertion in exon 11, c.903-904 dupGA, p.Leu302Aspfx49X, is associated with a relatively mild clinical presentation as the patient is the only one capable of sitting and walking alone. Of the six mutations, two are de novo missense changes affecting highly conserved aminoacid residues, c.215 T>C p.Ile72Thr and c.380A>G p.His127Arg (present in a mosaic condition) found in two girls with the most severe clinical presentation, while the remaining are the splicing c.145+2 T>C and c.2376+5G>A, the c.1648C>T p.Arg550X and the MPLA-identified c.162-99del261 mutation. RNA characterisation of four mutations revealed the aberrant transcript of the missense allele (case 2) and not the stop mutation (case 3), but also allowed the splicing mutation (case 1) and the c.-162-99del261 (case 4) to be categorised as truncating. The obtained data reinforce the view that a more severe phenotype is due more to an altered protein than haploinsufficiency. Furthermore, the mutational repertoire of the CDKL5 gene is shown to be expanded by testing patients with phenotypical overlap to Rett syndrome and applying multiplex ligation-dependent probe amplification.

AB - It has been found that CDKL5 gene mutations are responsible for early-onset epilepsy and drug resistance. We screened a population of 92 patients with classic/atypical Rett syndrome, 17 Angelman/Angelman-like patients and six idiopathic autistic patients for CDKL5 mutations and exon deletions and identified seven novel mutations: six in the Rett subset and one in an Angelman patient. This last, an insertion in exon 11, c.903-904 dupGA, p.Leu302Aspfx49X, is associated with a relatively mild clinical presentation as the patient is the only one capable of sitting and walking alone. Of the six mutations, two are de novo missense changes affecting highly conserved aminoacid residues, c.215 T>C p.Ile72Thr and c.380A>G p.His127Arg (present in a mosaic condition) found in two girls with the most severe clinical presentation, while the remaining are the splicing c.145+2 T>C and c.2376+5G>A, the c.1648C>T p.Arg550X and the MPLA-identified c.162-99del261 mutation. RNA characterisation of four mutations revealed the aberrant transcript of the missense allele (case 2) and not the stop mutation (case 3), but also allowed the splicing mutation (case 1) and the c.-162-99del261 (case 4) to be categorised as truncating. The obtained data reinforce the view that a more severe phenotype is due more to an altered protein than haploinsufficiency. Furthermore, the mutational repertoire of the CDKL5 gene is shown to be expanded by testing patients with phenotypical overlap to Rett syndrome and applying multiplex ligation-dependent probe amplification.

KW - Genotype-phenotype correlation

KW - Mutation screening

KW - RNA analysis

UR - http://www.scopus.com/inward/record.url?scp=70249084575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249084575&partnerID=8YFLogxK

U2 - 10.1007/s10048-009-0177-1

DO - 10.1007/s10048-009-0177-1

M3 - Article

C2 - 19241098

AN - SCOPUS:70249084575

VL - 10

SP - 241

EP - 250

JO - Neurogenetics

JF - Neurogenetics

SN - 1364-6745

IS - 3

ER -